Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Squarer Ron, Director. Insider active across 3 companies, notably Travere Therapeutics, Inc.. Aggregated, 13 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €19k. Activity tracked since 14 May 2021. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Squarer Ron is Administrateur at ADC Therapeutics SA, Travere Therapeutics, Inc. and Nuvalent, Inc. He has 13 filings in total; across the 13 most recent sampled filings, the observed amounts are EUR 0 in purchases and EUR 18821 in sales, from 2021-05-18 to 2026-07-15. The most frequent transaction nature is Attribution.